These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26795750)

  • 1. Acquired C1 esterase inhibitor deficiency in lymphomas: prevalence, symptoms, and response to treatment.
    Bekos C; Perkmann T; Krauth M; Raderer M; Lechner K; Jaeger U
    Leuk Lymphoma; 2016 Sep; 57(9):2033-6. PubMed ID: 26795750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibitor deficiency.
    Castelli R; Wu MA; Arquati M; Zanichelli A; Suffritti C; Rossi D; Cicardi M
    Br J Haematol; 2016 Mar; 172(6):902-8. PubMed ID: 26728240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired Angioedema due to C1 Inhibitor Deficiency Preceding Splenic Marginal Zone Lymphoma: Further Insights from Clinical Practice.
    Ferriani MPL; Trevisan-Neto O; Costa JS; Melo JML; Moreno AS; Dias MM; Garibaldi PMM; Pereira GC; Chahud F; Traina F; Arruda LK
    Int Arch Allergy Immunol; 2020; 181(12):941-946. PubMed ID: 32894844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenic marginal zone lymphomas in acquired C1-inhibitor deficiency: clinical and molecular characterization.
    Sbattella M; Zanichelli A; Ghia P; Gattei V; Suffritti C; Teatini T; Cicardi M; Castelli R
    Med Oncol; 2018 Aug; 35(9):118. PubMed ID: 30073422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Levels of the Lectin Pathway Serine Protease MASP-1 and Its Complex Formation with C1 Inhibitor Are Linked to the Severity of Hereditary Angioedema.
    Hansen CB; Csuka D; Munthe-Fog L; Varga L; Farkas H; Hansen KM; Koch C; Skjødt K; Garred P; Skjoedt MO
    J Immunol; 2015 Oct; 195(8):3596-604. PubMed ID: 26371246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline level of functional C1-inhibitor correlates with disease severity scores in hereditary angioedema.
    Kelemen Z; Moldovan D; Mihály E; Visy B; Széplaki G; Csuka D; Füst G; Farkas H; Varga L
    Clin Immunol; 2010 Mar; 134(3):354-8. PubMed ID: 19945350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency.
    Zanichelli A; Azin GM; Wu MA; Suffritti C; Maggioni L; Caccia S; Perego F; Vacchini R; Cicardi M
    J Allergy Clin Immunol Pract; 2017; 5(5):1307-1313. PubMed ID: 28284781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recurrent isolated angioedema as a result of acquired C1 inhibitor deficiency].
    Bosma J; Bijl JM; Siegert CE; Vasmel WL
    Ned Tijdschr Geneeskd; 2014; 158():A7184. PubMed ID: 24666532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired angioedema associated with hereditary angioedema due to C1 inhibitor deficiency.
    Guilarte M; Luengo O; Nogueiras C; Labrador-Horrillo M; Muñoz E; López A; Cardona V
    J Investig Allergol Clin Immunol; 2008; 18(2):126-30. PubMed ID: 18447143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressed classical complement pathway activities in chronic lymphocytic leukaemia.
    Füst G; Czink E; Minh D; Miszlay Z; Varga L; Hollán SR
    Clin Exp Immunol; 1985 Jun; 60(3):489-95. PubMed ID: 4017286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of lymphoproliferative disorders and of anti-C1 inhibitor autoantibodies in acquired angio-oedema.
    Cicardi M; Beretta A; Colombo M; Gioffré D; Cugno M; Agostoni A
    Clin Exp Immunol; 1996 Dec; 106(3):475-80. PubMed ID: 8973615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies.
    Cicardi M; Zingale LC; Pappalardo E; Folcioni A; Agostoni A
    Medicine (Baltimore); 2003 Jul; 82(4):274-81. PubMed ID: 12861105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel prophylaxis with C1-inhibitor concentrate in hereditary angioedema during erythema marginatum.
    Kőhalmi KV; Veszeli N; Cervenak L; Varga L; Farkas H
    Immunol Lett; 2017 Sep; 189():90-93. PubMed ID: 28577900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of hereditary angioedema.
    Canonica GW; Rossi O
    Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoma-associated paraneoplastic angioedema with normal C1-inhibitor activity: does danazol work?
    Gaur S; Cooley J; Aish L; Weinstein R
    Am J Hematol; 2004 Nov; 77(3):296-8. PubMed ID: 15495244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy.
    Zanichelli A; Arcoleo F; Barca MP; Borrelli P; Bova M; Cancian M; Cicardi M; Cillari E; De Carolis C; De Pasquale T; Del Corso I; Di Rocco PC; Guarino MD; Massaro I; Minale P; Montinaro V; Neri S; Perricone R; Pucci S; Quattrocchi P; Rossi O; Triggiani M; Zanierato G; Zoli A
    Orphanet J Rare Dis; 2015 Feb; 10():11. PubMed ID: 25758562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary angioedema: a Taiwanese family with a novel gene mutation.
    Wen DC; Shyur SD; Wu JY; Lin CC; Chiang YC; Huang LH; Lin MT; Yang HC; Liang PH
    Asian Pac J Allergy Immunol; 2007; 25(2-3):163-7. PubMed ID: 18035804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of thromboembolism in patients with hereditary angioedema treated with plasma-derived C1-inhibitor.
    Farkas H; Kőhalmi KV; Veszeli N; Zotter Z; Várnai K; Varga L
    Allergy Asthma Proc; 2016; 37(2):164-70. PubMed ID: 26802388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema.
    Madsen DE; Sidelmann JJ; Biltoft D; Gram J; Hansen S
    Biochim Biophys Acta; 2015 Jun; 1850(6):1336-42. PubMed ID: 25800206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete kinetic follow-up of symptoms and complement parameters during a hereditary angioedema attack.
    Veszeli N; Kőhalmi KV; Kajdácsi E; Gulyás D; Temesszentandrási G; Cervenak L; Farkas H; Varga L
    Allergy; 2018 Feb; 73(2):516-520. PubMed ID: 28986975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.